Liraglutide (Saxenda / Victoza)
Daily GLP-1 receptor agonist. FDA-approved 2010 (Victoza, T2D) and 2014 (Saxenda, obesity). The first wave of modern GLP-1 weight-loss therapy and direct predecessor to Semaglutide.
Liraglutide (Saxenda / Victoza): Daily GLP-1 receptor agonist. FDA-approved 2010 (Victoza, T2D) and 2014 (Saxenda, obesity). The first wave of modern GLP-1 weight-loss therapy and direct predecessor to Semaglutide. Liraglutide is the daily-injection GLP-1 that came before Semaglutide.
Liraglutide is the daily-injection GLP-1 that came before Semaglutide. Sold as Saxenda for weight loss and Victoza for diabetes. Same family as Wegovy/Ozempic but you inject it every day instead of weekly. Less convenient, but covered by some insurance plans that don't cover the weekly versions.
Approved as Victoza (2010, type 2 diabetes) and Saxenda (2014, obesity). Both Novo Nordisk.
Yes, primary care, endocrinology, and obesity-medicine specialists prescribe widely.
Who it's for
- →Patients on insurance plans that cover Saxenda but not Wegovy
- →Users who don't tolerate weekly Semaglutide titration
- →Educational reference for the GLP-1 class lineage
What to expect
- Week 1
Appetite drops. Mild nausea common.
- Week 4
First titration step. ~2-4 lb down typical.
- Week 8
Cumulative loss 5-10 lb for most users.
Looking at Liraglutide (Saxenda / Victoza)? Your next 3 steps
- 1Work out your exact dose
Vial size + BAC water turns into the exact units to draw for Liraglutide (Saxenda / Victoza).
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account saves your stack; membership adds the stack-aware AI Coach.
Create free account →
How it works (mechanism)
Daily-injection GLP-1 agonist with fatty-acid modification that allows albumin binding for ~13-hour half-life. Same receptor as Semaglutide; shorter duration means daily injection.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠MTC / MEN-2 history (boxed warning)
- ⚠Pancreatitis history
- ⚠Pregnancy / nursing
- ⚠Severe hypersensitivity
Bloodwork to monitor
- • Lipid panel
- • ALT/AST
- • A1C if metabolic context
Common mistakes
- • Skipping titration steps
- • Treating it as Semaglutide-equivalent (daily vs weekly is a real burden difference)
- • Stopping abruptly without a maintenance plan
Drug & supplement interactions
- ⚠Insulin and sulfonylureas: dose reduction usually needed to prevent hypoglycemia
- ⚠Slows gastric emptying, affects oral medication absorption
- ⚠Avoid alcohol during titration
Community patterns
New to Liraglutide (Saxenda / Victoza)? Grab the starter checklist.
Drop your email and we'll send the one-page first-cycle starter checklist, plus a heads-up if Liraglutide (Saxenda / Victoza) changes legal status. No account needed.
No spam. No selling your email. Just the checklist and the occasional reclassification alert.
Ask the Coach anything about Liraglutide (Saxenda / Victoza) or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Get the Coach, $7.99/mo →Frequently asked
What is Liraglutide (Saxenda / Victoza)?+
Is Liraglutide (Saxenda / Victoza) FDA approved?+
Is Liraglutide (Saxenda / Victoza) legal?+
Is Liraglutide (Saxenda / Victoza) banned by WADA?+
Are you still natty after taking Liraglutide (Saxenda / Victoza)?+
Do doctors prescribe Liraglutide (Saxenda / Victoza)?+
What's the typical dose of Liraglutide (Saxenda / Victoza)?+
What are the side effects of Liraglutide (Saxenda / Victoza)?+
How long until Liraglutide (Saxenda / Victoza) starts working?+
What can you stack with Liraglutide (Saxenda / Victoza)?+
Where do people get Liraglutide (Saxenda / Victoza)?+
More in Fat Loss
Strong weight loss with a cleaner side effect profile than semaglutide. A dual agonist (GLP-1 + GIP), FDA-approved as Mounjaro / Zepbound.
The original weight-loss wave, sold as Ozempic / Wegovy. A GLP-1 agonist.
Triple agonist (GLP-1 + GIP + glucagon) from Eli Lilly. In trials it outperforms Tirzepatide for weight loss.
An appetite-control shot for weight loss. A long-acting amylin agonist that works on a different pathway than the GLP-1 drugs, often paired with Semaglutide as 'CagriSema' to break GLP-1 plateaus.